Organoidsciences Ltd

476040

Company Profile

  • Business description

    Organoidsciences Ltd is a biotechnology company specializing in organoid technology, developing regenerative therapeutics and drug discovery solutions based on three-dimensional organoids. Its business includes ATORM, an organoid-based regenerative therapeutics pipeline, and ODISEI, an organoid-based drug discovery platform. ATORM is a regenerative therapeutic pipeline leveraging organoids derived from various human tissues, including the intestine and salivary gland, to develop novel treatments for a wide range of diseases. ODISEI is an organoid-based drug discovery solution that utilizes disease-specific organoids-including tumor, viral infection, intestinal, and skin organoids-to predict and evaluate human biological responses.

  • Contact

    338 Pangyo-ro
    6th floor, Bundang-gu
    Gyeonggi-do
    Seongnam-si
    KOR

    T: +82 27072024

    https://organoidrx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    86

Stocks News & Analysis

stocks

Steep downgrade for wide moat share

Regulatory pressures squeeze growth outlook for wide moat ASX share.
stocks

The strange effect of the 30% minimum capital gains tax

How the proposed CGT floor creates unexpected outcomes across different incomes.
stocks

ASX restaurant chain remains cheap

Is the market overlooking this undervalued fast food chain?

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,979.3038.700.43%
CAC 408,252.66183.58-2.18%
DAX 4024,897.45567.80-2.23%
Dow JONES (US)52,335.48589.67-1.11%
FTSE 10010,489.04176.84-1.66%
HKSE24,199.46702.572.99%
NASDAQ25,823.825.130.02%
Nikkei 22566,819.051,437.91-2.11%
NZX 50 Index13,665.1897.61-0.71%
S&P 5007,478.9024.95-0.33%
S&P/ASX 2008,785.1047.500.54%
SSE Composite Index3,970.8819.36-0.49%

Market Movers